Geode Capital Management’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-336,879
| Closed | -$555K | – | 5088 |
|
|
2022
Q1 | $555K | Sell |
336,879
-1,541
| -0.5% | -$2.54K | ﹤0.01% | 3884 |
|
|
2021
Q4 | $808K | Sell |
338,420
-36,181
| -10% | -$86.4K | ﹤0.01% | 3810 |
|
|
2021
Q3 | $2.05M | Buy |
374,601
+35,296
| +10% | +$193K | ﹤0.01% | 3342 |
|
|
2021
Q2 | $2.52M | Buy |
339,305
+72,001
| +27% | +$536K | ﹤0.01% | 3193 |
|
|
2021
Q1 | $2.17M | Buy |
267,304
+57,452
| +27% | +$465K | ﹤0.01% | 3221 |
|
|
2020
Q4 | $1.91M | Buy |
209,852
+38,220
| +22% | +$348K | ﹤0.01% | 3112 |
|
|
2020
Q3 | $1.9M | Buy |
171,632
+33,772
| +24% | +$374K | ﹤0.01% | 2896 |
|
|
2020
Q2 | $1.02M | Buy |
137,860
+6,631
| +5% | +$49.3K | ﹤0.01% | 3128 |
|
|
2020
Q1 | $807K | Buy |
131,229
+19,371
| +17% | +$119K | ﹤0.01% | 3097 |
|
|
2019
Q4 | $561K | Buy |
111,858
+33,937
| +44% | +$170K | ﹤0.01% | 3462 |
|
|
2019
Q3 | $586K | Buy |
77,921
+103
| +0.1% | +$775 | ﹤0.01% | 3414 |
|
|
2019
Q2 | $902K | Buy |
+77,818
| New | +$902K | ﹤0.01% | 3265 |
|